BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9858423)

  • 1. Ferritin subunits in sera and synovial fluids from patients with rheumatoid arthritis.
    Ota T; Katsuki I
    J Rheumatol; 1998 Dec; 25(12):2315-8. PubMed ID: 9858423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells.
    Yukioka K; Inaba M; Furumitsu Y; Yukioka M; Nishino T; Goto H; Nishizawa Y; Morii H
    J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis.
    Matsuyama Y; Okazaki H; Tamemoto H; Kimura H; Kamata Y; Nagatani K; Nagashima T; Hayakawa M; Iwamoto M; Yoshio T; Tominaga S; Minota S
    J Rheumatol; 2010 Jan; 37(1):18-25. PubMed ID: 19918048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
    Tokayer A; Carsons SE; Chokshi B; Santiago-Schwarz F
    J Rheumatol; 2002 Mar; 29(3):454-61. PubMed ID: 11908556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.
    Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.
    Blaschke S; Schulz H; Schwarz G; Blaschke V; Müller GA; Reuss-Borst M
    J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis.
    Neidhart M; Wehrli R; Brühlmann P; Michel BA; Gay RE; Gay S
    Arthritis Rheum; 1999 Apr; 42(4):622-30. PubMed ID: 10211875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis.
    Schlenk J; Lorenz HM; Haas JP; Herrmann M; Hohenberger G; Kalden JR; Röllinghoff M; Beuscher HU
    J Rheumatol; 2005 Dec; 32(12):2291-8. PubMed ID: 16331752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced local production of osteopontin in rheumatoid joints.
    Ohshima S; Yamaguchi N; Nishioka K; Mima T; Ishii T; Umeshita-Sasai M; Kobayashi H; Shimizu M; Katada Y; Wakitani S; Murata N; Nomura S; Matsuno H; Katayama R; Kon S; Inobe M; Uede T; Kawase I; Saeki Y
    J Rheumatol; 2002 Oct; 29(10):2061-7. PubMed ID: 12375312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyamine levels in synovial tissues and synovial fluids of patients with rheumatoid arthritis.
    Yukioka K; Wakitani S; Yukioka M; Furumitsu Y; Shichikawa K; Ochi T; Goto H; Matsui-Yuasa I; Otani S; Nishizawa Y
    J Rheumatol; 1992 May; 19(5):689-92. PubMed ID: 1613696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients.
    Reparon-Schuijt CC; van Esch WJ; van Kooten C; Levarht EW; Breedveld FC; Verweij CL
    Arthritis Rheum; 1998 Dec; 41(12):2211-20. PubMed ID: 9870878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANTES and chemotactic activity in synovial fluids from patients with rheumatoid arthritis and osteoarthritis.
    Stanczyk J; Kowalski ML; Grzegorczyk J; Szkudlinska B; Jarzebska M; Marciniak M; Synder M
    Mediators Inflamm; 2005 Dec; 2005(6):343-8. PubMed ID: 16489254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
    Kim HR; Park MK; Cho ML; Yoon CH; Lee SH; Park SH; Leng L; Bucala R; Kang I; Choe J; Kim HY
    J Rheumatol; 2007 May; 34(5):927-36. PubMed ID: 17407222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients.
    Hock BD; O'Donnell JL; Taylor K; Steinkasserer A; McKenzie JL; Rothwell AG; Summers KL
    Tissue Antigens; 2006 Jan; 67(1):57-60. PubMed ID: 16451202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.
    Cho ML; Min SY; Chang SH; Kim KW; Heo SB; Lee SH; Park SH; Cho CS; Kim HY
    Immunol Lett; 2006 Jun; 105(2):159-66. PubMed ID: 16564576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.